Antares Pharma Inc (ATRS) Inventory Turnover Ratio, from first quarter 2022 to first quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Antares Pharma Inc   (NASDAQ: ATRS)
 

Antares Pharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Antares Pharma Inc inventory turnover ratio, the Antares Pharma Inc 's ability to sell and replace its inventory in the first quarter 2022, sequentially increased to 3.95 in the first quarter 2022, yet the ratio remained below the average, as ATRS's market remain challenging.Average inventory processing period, for the Antares Pharma Inc in Mar 31 2022 quarter, has decreased to 92 days, compare to 111 days, in the Dec 31 2021 quarter.

Within Healthcare sector 120 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1128 in the fourth quarter 2021, to 1133.

ATRS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Antares Pharma Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATRS Inventory Turnover Ratio (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Inventory Growth -40.9 % -36.63 % -16.74 % -4.9 % 13.32 %
Y / Y Cost of Sales Growth 25.2 % 63.84 % -15 % -6.79 % -16.94 %
Inventory Turnover Ratio (TTM) 3.95 3.28 2.64 2.65 2.66
ATRS's Total Ranking # 1133 # 1128 # 1121 # 1121 # 1128
Average inventory processing period 92 111 138 138 137
Seq. Inventory Growth 0.41 % -30.01 % -11.54 % -4.95 % 7.67 %
Seq. Cost of Sales Growth -3.71 % 15.76 % 20.71 % -6.95 % 26 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 121
Overall Market # 1133

Inventory Turnover Ratio Statistics
High Average Low
11.63 3.96 0.86
(Jun 30 2013)   (Sep 30 2014)



ATRS Company Profile >> Back to ATRS Efficiency Comparisons >> Compare ATRS Inventory Turnover Ratio to its Competitors

Financial Statements
Antares Pharma Inc 's Inventories $ 12 Millions Visit ATRS's Balance sheet
Antares Pharma Inc 's Cost of Revenues TTM $ 58 Millions Visit ATRS's Income Statement
What are ATRS's Sales? Visit ATRS's Sales by Segment

Other Inventory Turnover Ratios
Antares Pharma Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ATRS's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ATRS's Competitors
Inventory Turnover Ratio for ATRS's Suppliers
Inventory Turnover Ratio for ATRS's Customers

You may also want to know
ATRS's Sales Growth Rates ATRS's Pe Price to earnings ratio ATRS's Receivables Turnover Ratio ATRS's Stock Quote
ATRS's Net Income Growth Rates ATRS's Ps Price to Sales ratio ATRS's Sales per Employee ATRS's Asset Turnover Ratio
ATRS's Net Margin ATRS's Pb Price to Book ratio ATRS's Financial Strength Ratios ATRS's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2022 Inventories at quarter ending Mar 31 2022
Lifemd Inc   13.03 $ 19.732  Millions$ 2  Millions
Harmony Biosciences Holdings inc   12.74 $ 59.825  Millions$ 5  Millions
Natera Inc   12.67 $ 343.300  Millions$ 27  Millions
Cannabis Global Inc.  11.83 $ 2.633  Millions$ 0  Millions
Precipio inc   11.79 $ 6.845  Millions$ 1  Millions
Infusystem Holdings Inc  11.47 $ 43.694  Millions$ 4  Millions
Myriad Genetics Inc   11.29 $ 189.600  Millions$ 17  Millions
Irhythm Holdings Inc   11.10 $ 116.419  Millions$ 10  Millions
Invitae Corporation  10.77 $ 370.294  Millions$ 34  Millions
Cryo cell International Inc   10.17 $ 9.081  Millions$ 1  Millions
Zymergen Inc.  10.09 $ 61.046  Millions$ 6  Millions
Sotera Health Company  9.79 $ 423.909  Millions$ 43  Millions
Qhslab Inc   9.68 $ 0.740  Millions$ 0  Millions
Charles River Laboratories International inc   9.55 $ 1,900.376  Millions$ 199  Millions
Camp4 Therapeutics Corporation  9.46 $ 173.953  Millions$ 18  Millions
23andme Holding Co  9.12 $ 138.948  Millions$ 15  Millions
Opko Health Inc   9.08 $ 983.945  Millions$ 108  Millions
Star Equity Holdings Inc   9.06 $ 92.428  Millions$ 10  Millions
Nutriband Inc   8.99 $ 1.026  Millions$ 0  Millions
Advanced Container Technologies Inc   8.89 $ 3.301  Millions$ 0  Millions
Biotricity Inc   8.72 $ 3.080  Millions$ 0  Millions
Castle Biosciences Inc   8.45 $ 18.738  Millions$ 2  Millions
Vyant Bio Inc   8.43 $ 3.919  Millions$ 0  Millions
Sunlink Health Systems Inc   8.31 $ 15.830  Millions$ 2  Millions
Cryoport inc   7.99 $ 127.258  Millions$ 16  Millions
Lantheus Holdings Inc   7.87 $ 265.844  Millions$ 34  Millions
Hims and Hers Health Inc   7.59 $ 81.875  Millions$ 11  Millions
National Vision Holdings Inc   7.38 $ 916.126  Millions$ 124  Millions
Kewaunee Scientific Corporation  7.26 $ 144.652  Millions$ 20  Millions
Revvity Inc  7.21 $ 3,935.583  Millions$ 546  Millions

Date modified: 2026-08-29T17:23:07+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.